Table: Kyorin Pharmaceutical -Q1 group results

Kyorin Pharmaceutical

30/07/2026 07:31

    Jul 30 (Reuters)- 
             Kyorin Pharmaceutical Co., Ltd. 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended       Year to 
                Jun 30, 2026        Jun 30, 2025     Mar 31, 2027 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             29.65               30.23           121.80    
                 (-1.9 pct)          (+6.4 pct)       (-3.5 pct)  
  Operating        964 mln               2.37             2.00    
                 (-59.3 pct)        (+106.0 pct)      (-43.9 pct) 
  Recurring          1.24                2.62             2.30    
                 (-52.7 pct)         (+85.1 pct)      (-42.9 pct) 
  Net              824 mln               2.10             1.50    
                 (-60.8 pct)        (+137.1 pct)      (-56.5 pct) 
  EPS             14.35 yen           36.57 yen        26.11 yen  
  Ann Div                             57.00 yen        25.00 yen  
  -Q2 div                             20.00 yen        10.00 yen  
  -Q4 div                             37.00 yen        15.00 yen  
  
  NOTE - Kyorin Pharmaceutical Co., Ltd.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4569.T